XML 32 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Schedule Of Other Financial Instruments In Carrying Values And Fair Values
Our other financial instruments had the following carrying values and fair values as of the dates shown (in thousands):
 
 
 
June 30, 2014
 
December 31, 2013
 
Level
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Non-recourse debt (a)
3
 
$
1,940,848

 
$
1,991,018

 
$
1,915,601

 
$
1,944,865

Note receivable (a)
3
 
40,000

 
42,760

 
40,000

 
43,890

Deferred acquisition fees payable (b)
3
 
9,153

 
10,261

 
15,033

 
15,950

Other securities (c)
3
 
10,385

 
10,385

 
9,915

 
15,548

CMBS (d)
3
 
3,126

 
9,446

 
2,791

 
6,052

___________
(a)
We determined the estimated fair value of these financial instruments using a discounted cash flow model with rates that take into account the credit of the tenant/obligor and interest rate risk. We also considered the value of the underlying collateral taking into account the quality of the collateral, the credit quality of the tenant/obligor, the time until maturity and the current market interest rate.
(b)
We determined the estimated fair value of our deferred acquisition fees based on an estimate of discounted cash flows using two significant unobservable inputs, which are the leverage adjusted unsecured spread and an illiquidity adjustment of 355 basis points and 75 basis points, respectively. Significant increases or decreases to these inputs in isolation would result in a significant change in the fair value measurement.
(c)
Amounts at June 30, 2014 primarily reflect our interest in a foreign debenture, which is included in Other assets, net in the consolidated financial statements. Amounts at December 31, 2013 reflect equity securities and an interest in a foreign debenture, both of which was included in Other assets, net in the consolidated financial statements. As of June 30, 2014, we converted the equity securities to an equity investment in real estate (Note 6).
(d)
The carrying value of our commercial mortgage-backed securities, or CMBS, is inclusive of accretion related to the estimated cash flows expected to be received. There were no purchases, sales, or impairment charges recognized during either the six months ended June 30, 2014 or 2013.